These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 26671103)
1. The susceptibility vessel sign containing two compositions on 3-tesla T2*-weighted image and single corticosubcortical infarct on diffusion-weighted image are associated with cardioembolic stroke. Yamamoto N; Satomi J; Yamamoto Y; Yamaguchi I; Furukawa T; Tada Y; Harada M; Izumi Y; Nagahiro S; Kaji R J Neurol Sci; 2015 Dec; 359(1-2):141-5. PubMed ID: 26671103 [TBL] [Abstract][Full Text] [Related]
2. Two-layered susceptibility vessel sign on 3-tesla T2*-weighted imaging is a predictive biomarker of stroke subtype. Yamamoto N; Satomi J; Tada Y; Harada M; Izumi Y; Nagahiro S; Kaji R Stroke; 2015 Jan; 46(1):269-71. PubMed ID: 25477219 [TBL] [Abstract][Full Text] [Related]
3. Advantages of susceptibility-weighted magnetic resonance sequences in the visualization of intravascular thrombi in acute ischemic stroke. Allibert R; Billon Grand C; Vuillier F; Cattin F; Muzard E; Biondi A; Moulin T; Medeiros E Int J Stroke; 2014 Dec; 9(8):980-4. PubMed ID: 25319168 [TBL] [Abstract][Full Text] [Related]
4. Significance of susceptibility vessel sign on T2*-weighted gradient echo imaging for identification of stroke subtypes. Cho KH; Kim JS; Kwon SU; Cho AH; Kang DW Stroke; 2005 Nov; 36(11):2379-83. PubMed ID: 16224077 [TBL] [Abstract][Full Text] [Related]
5. Validation of overestimation ratio and TL-SVS as imaging biomarker of cardioembolic stroke and time from onset to MRI. Bourcier R; Legrand L; Soize S; Labreuche J; Beaumont M; Desal H; Derraz I; Bracard S; Oppenheim C; Naggara O; Eur Radiol; 2019 May; 29(5):2624-2631. PubMed ID: 30421018 [TBL] [Abstract][Full Text] [Related]
6. Ischemic findings of T2*-weighted 3-tesla MRI in acute stroke patients. Morita N; Harada M; Uno M; Matsubara S; Matsuda T; Nagahiro S; Nishitani H Cerebrovasc Dis; 2008; 26(4):367-75. PubMed ID: 18728364 [TBL] [Abstract][Full Text] [Related]
7. Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator. Derex L; Nighoghossian N; Hermier M; Adeleine P; Berthezène Y; Philippeau F; Honnorat J; Froment JC; Trouillas P J Neurol Sci; 2004 Oct; 225(1-2):3-9. PubMed ID: 15465079 [TBL] [Abstract][Full Text] [Related]
8. Acute stroke with major intracranial vessel occlusion: Characteristics of cardioembolism and atherosclerosis-related in situ stenosis/occlusion. Horie N; Tateishi Y; Morikawa M; Morofuji Y; Hayashi K; Izumo T; Tsujino A; Nagata I; Matsuo T J Clin Neurosci; 2016 Oct; 32():24-9. PubMed ID: 27506779 [TBL] [Abstract][Full Text] [Related]
10. Prediction of Stroke Subtype and Recanalization Using Susceptibility Vessel Sign on Susceptibility-Weighted Magnetic Resonance Imaging. Kang DW; Jeong HG; Kim DY; Yang W; Lee SH Stroke; 2017 Jun; 48(6):1554-1559. PubMed ID: 28432264 [TBL] [Abstract][Full Text] [Related]
11. Predictive value of thrombus susceptibility for cardioembolic stroke by quantitative susceptibility mapping. Chen J; Zhang Z; Nie X; Xu Y; Liu C; Zhao X; Wang Y Quant Imaging Med Surg; 2022 Jan; 12(1):550-557. PubMed ID: 34993100 [TBL] [Abstract][Full Text] [Related]
12. Occlusive vessel signs on MRI as only findings of hyperacute ischemic stroke. Inatomi Y; Yonehara T; Hashimoto Y; Hirano T; Uchino M J Neurol Sci; 2008 May; 268(1-2):187-9. PubMed ID: 18061207 [TBL] [Abstract][Full Text] [Related]
13. [Susceptibility vessel sign in subacute stroke patients with large vessel occlusion]. Ren GY; Wu XM; Li Y; Li JY; Sun WP; Huang YN Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1133-1138. PubMed ID: 34916694 [TBL] [Abstract][Full Text] [Related]
14. Non-conventional risk factors were associated with infarct patterns in ischemic stroke. Yoon SR; Bang OY; Hong JM; Li WY; Lee PH; Ovbiagele B Clin Neurol Neurosurg; 2009 Feb; 111(2):134-9. PubMed ID: 18980799 [TBL] [Abstract][Full Text] [Related]
15. Frequency, Determinants, and Outcomes of Emboli to Distal and New Territories Related to Mechanical Thrombectomy for Acute Ischemic Stroke. Wong GJ; Yoo B; Liebeskind D; Baharvahdat H; Gornbein J; Jahan R; Szeder V; Duckwiler G; Tateshima S; Colby G; Nour M; Sharma L; Rao N; Hinman J; Starkman S; Saver JL; Stroke; 2021 Jul; 52(7):2241-2249. PubMed ID: 34011171 [TBL] [Abstract][Full Text] [Related]
16. [Application of diffusion-weighted and perfusion magnetic resonance imaging in definition of the ischemic penumbra in hyperacute cerebral infarction]. Feng XY; Liang J; Yin XD; Han X; Dong Q; Lü CZ Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):952-7. PubMed ID: 12899795 [TBL] [Abstract][Full Text] [Related]
17. Overestimation of Susceptibility Vessel Sign: A Predictive Marker of Stroke Cause. Zhang R; Zhou Y; Liu C; Zhang M; Yan S; Liebeskind DS; Lou M Stroke; 2017 Jul; 48(7):1993-1996. PubMed ID: 28536172 [TBL] [Abstract][Full Text] [Related]
18. Is the Susceptibility Vessel Sign on 3-Tesla Magnetic Resonance T2*-Weighted Imaging a Useful Tool to Predict Recanalization in Intravenous Tissue Plasminogen Activator? Yamamoto N; Satomi J; Harada M; Izumi Y; Nagahiro S; Kaji R Clin Neuroradiol; 2016 Sep; 26(3):317-23. PubMed ID: 25516146 [TBL] [Abstract][Full Text] [Related]
19. Large vessel cardioembolic stroke and embolic stroke of undetermined source share a common profile of matrix metalloproteinase-9 level and susceptibility vessel sign length. Alhazmi H; Bani-Sadr A; Bochaton T; Paccalet A; Da Silva CC; Buisson M; Amaz C; Ameli R; Berthezene Y; Eker OF; Ovize M; Cho TH; Nighoghossian N; Mechtouff L Eur J Neurol; 2021 Jun; 28(6):1977-1983. PubMed ID: 33682255 [TBL] [Abstract][Full Text] [Related]
20. M1 susceptibility vessel sign on T2* as a strong predictor for no early recanalization after IV-t-PA in acute ischemic stroke. Kimura K; Iguchi Y; Shibazaki K; Watanabe M; Iwanaga T; Aoki J Stroke; 2009 Sep; 40(9):3130-2. PubMed ID: 19556532 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]